These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 27842546)

  • 21. Expression and purification of cysteine introduced recombinant saporin.
    Günhan E; Swe M; Palazoglu M; Voss JC; Chalupa LM
    Protein Expr Purif; 2008 Apr; 58(2):203-9. PubMed ID: 18164211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding of urokinase plasminogen activator to gp130 via a putative urokinase-binding consensus sequence.
    Liang OD; Chavakis T; Linder M; Bdeir K; Kuo A; Preissner KT
    Biol Chem; 2003 Feb; 384(2):229-36. PubMed ID: 12675515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancing the production of Fc fusion protein in fed-batch fermentation of Pichia pastoris by design of experiments.
    Lin H; Kim T; Xiong F; Yang X
    Biotechnol Prog; 2007; 23(3):621-5. PubMed ID: 17461547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wortmannin, a phosphoinositide 3-kinase inhibitor, selectively enhances cytotoxicity of receptor-directed-toxin chimeras in vitro and in vivo.
    Davol PA; Bizuneh A; Frackelton AR
    Anticancer Res; 1999; 19(3A):1705-13. PubMed ID: 10470104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Biological function of fusion protein ATF-PAI2CD].
    Wang X; Li P; Zhang YQ; Hou M; Sun XH; Tan L; Zhu YS
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Jul; 35(7):624-8. PubMed ID: 12883632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitronectin binding to urokinase receptor in human breast cancer.
    Carriero MV; Del Vecchio S; Franco P; Potena MI; Chiaradonna F; Botti G; Stoppelli MP; Salvatore M
    Clin Cancer Res; 1997 Aug; 3(8):1299-308. PubMed ID: 9815812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and anticancer activity analysis of recombinant human uPA1‑43-melittin.
    Su M; Chang W; Cui M; Lin Y; Wu S; Xu T
    Int J Oncol; 2015 Feb; 46(2):619-26. PubMed ID: 25394558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction in human osteoblastic cells (SaOS2) of the early response genes fos, jun, and myc by the amino terminal fragment (ATF) of urokinase.
    Rabbani SA; Gladu J; Mazar AP; Henkin J; Goltzman D
    J Cell Physiol; 1997 Aug; 172(2):137-45. PubMed ID: 9258335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo suppression of vein graft disease by nonviral, electroporation-mediated, gene transfer of tissue inhibitor of metalloproteinase-1 linked to the amino terminal fragment of urokinase (TIMP-1.ATF), a cell-surface directed matrix metalloproteinase inhibitor.
    Eefting D; de Vries MR; Grimbergen JM; Karper JC; van Bockel JH; Quax PH
    J Vasc Surg; 2010 Feb; 51(2):429-37. PubMed ID: 20036101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro and in vivo anti-tumor effect of Trichobakin fused with urokinase-type plasminogen activator ATF-TBK.
    Pham DD; Pham TH; Bui TH; Britikova EV; Britikov VV; Bocharov EV; Usanov SA; Phan VC; Le TBT
    Mol Biol Rep; 2024 Jan; 51(1):130. PubMed ID: 38236367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimization of human serum albumin production in methylotrophic yeast Pichia pastoris by repeated fed-batch fermentation.
    Ohya T; Ohyama M; Kobayashi K
    Biotechnol Bioeng; 2005 Jun; 90(7):876-87. PubMed ID: 15864809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urokinase plasminogen activator and urokinase plasminogen activator receptor mediate human stem cell tropism to malignant solid tumors.
    Gutova M; Najbauer J; Frank RT; Kendall SE; Gevorgyan A; Metz MZ; Guevorkian M; Edmiston M; Zhao D; Glackin CA; Kim SU; Aboody KS
    Stem Cells; 2008 Jun; 26(6):1406-13. PubMed ID: 18403751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production and characterization of recombinant 9 and 15 kDa granulysin by fed-batch fermentation in Pichia pastoris.
    Guo Y; Luan G; Shen G; Wu L; Jia H; Zhong Y; Li R; Li G; Shen Y; Sun J; Hu S; Xiao W
    Appl Microbiol Biotechnol; 2013 Sep; 97(17):7669-77. PubMed ID: 23224405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant production of a hybrid plasminogen activator composed of surfactant protein B and low-molecular-weight urokinase.
    Ruppert C; Mahavadi P; Wygrecka M; Weaver TE; Magdolen V; Idell S; Preissner KT; Seeger W; Günther A; Markart P
    Thromb Haemost; 2008 Dec; 100(6):1185-92. PubMed ID: 19132247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of a hybrid gene consisting of the amino-terminal fragment of urokinase and carboxyl-terminal domain of bikunin suppresses invasion and migration of human ovarian cancer cells in vitro.
    Takei Y; Mizukami H; Saga Y; Kobayashi H; Suzuki M; Matsushita T; Ozawa K; Suzuki M
    Int J Cancer; 2005 Jan; 113(1):54-8. PubMed ID: 15386422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. uPA-silica-Particles (SP-uPA): a novel analytical system to investigate uPA-uPAR interaction and to test synthetic uPAR antagonists as potential cancer therapeutics.
    Guthaus E; Bürgle M; Schmiedeberg N; Hocke S; Eickler A; Kramer MD; Sweep CG; Magdolen V; Kessler H; Schmitt M
    Biol Chem; 2002 Jan; 383(1):207-16. PubMed ID: 11930939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel tumor targeting drug carrier for optical imaging and therapy.
    Li R; Zheng K; Hu P; Chen Z; Zhou S; Chen J; Yuan C; Chen S; Zheng W; Ma E; Zhang F; Xue J; Chen X; Huang M
    Theranostics; 2014; 4(6):642-59. PubMed ID: 24723985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High expression of the urokinase plasminogen activator and its cognate receptor associates with advanced stages and reduced disease-free interval in papillary thyroid carcinoma.
    Ulisse S; Baldini E; Sorrenti S; Barollo S; Gnessi L; Catania A; Pellizzo MR; Nardi F; Mian C; De Antoni E; D'Armiento M; Frati L
    J Clin Endocrinol Metab; 2011 Feb; 96(2):504-8. PubMed ID: 21106716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclo19,31[D-Cys19]-uPA19-31 is a potent competitive antagonist of the interaction of urokinase-type plasminogen activator with its receptor (CD87).
    Magdolen V; Bürgle M; de Prada NA; Schmiedeberg N; Riemer C; Schroeck F; Kellermann J; Degitz K; Wilhelm OG; Schmitt M; Kessler H
    Biol Chem; 2001 Aug; 382(8):1197-205. PubMed ID: 11592401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Constitutive expression of a rhIL-2-HSA fusion protein in Pichia pastoris using glucose as carbon source.
    Guan B; Chen F; Lei J; Li Y; Duan Z; Zhu R; Chen Y; Li H; Jin J
    Appl Biochem Biotechnol; 2013 Dec; 171(7):1792-804. PubMed ID: 23999737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.